title: Use of radioactive iodine I-131 and monitoring of radioactivity in patients with chronic kidney disease on haemodialysis.
abstract: Thyroid carcinoma is a neoplasia with a higher incidence in patients with chronic kidney disease. In recent years advances have been made in diagnostic and therapeutic trials. Dialysis patients are a particular group, their cancer being detected indirectly in the study of secondary hyperparathyroidism and during the study prior to renal transplantation. Thyroidectomy is the definitive treatment, but in patients with risk of recurrence, ablative therapy is required using radioactive iodine I-131, which is predominantly eliminated by renal excretion, therefore its use in patients on dialysis poses a problem in terms of dosage. Two cases are presented of patients on haemodialysis undergoing radioablation with radioactive iodine I-131, which with multidisciplinary treatment had the expected results in the patients.
authors.forename: Angel
authors.initials: A
authors.lastname: Gallegos-Villalobos
authors.forename: Fernando
authors.initials: F
authors.lastname: García-López
authors.forename: Carmen
authors.initials: C
authors.lastname: Escalada
authors.forename: Juan J
authors.initials: JJ
authors.lastname: Ortiz
authors.forename: Jorge
authors.initials: J
authors.lastname: Cardona
authors.forename: Amparo
authors.initials: A
authors.lastname: Medina
authors.forename: José
authors.initials: J
authors.lastname: Portolés
mesh_terms: D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D013964:Thyroid Neoplasms / Q000150:complications* / Q000532:radiotherapy*
chemical_list: D007457:Iodine Radioisotopes